Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: M. Ramle who wrote (899)	6/17/1998 12:40:00 AM
From: dave g	Respond to of 10280

I share your disgust!! I bought July 50 calls on this sucker when it hit 45. It really looked like it had some momentum and then splat. At least the resistance at 37-38 is holding. I still think that SEPR is a great long term buy because of it's position in the antihistamine. It seems to have a knack for making drugs safer.

To: M. Ramle who wrote (899)	6/17/1998 7:16:00 AM
From: billy d	Read Replies (1) \| Respond to of 10280

Mazen, I too am quite frustrated by SEPR's performance lately but have been through this many times before. As I have previously stated, looking at general market conditions and relative performance to its peers sometimes puts things in a better perspective for me. Many biotechs are well off their highs and most of them more then SEPR. Now granted SEPR has done worse then the overall market in the last 2 months but so have other companies in their sector. Also, keep in mind that according to Smart Money on-line, SEPR rose 166% last year. Some consolidation is not surprising to me. As for me I have been buying shares in the low 38's (38 1/2 yesterday) and selling in the low 40's. I do this only because these are margin trades. I do hold a bunch of shares that I do not trade but one thing I am relatively sure of. Sometime soon I will sell some shares in the 40's and this baby will keep on going up! Keep the faith.